[Seite 87↓]


[1] Marshall, B. J. und Warren, J. R. (1984): Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration, Lancet 1 [8390], Seite 1311-1315.

[2] Warren, J. R. und Marshall, B. J. (1983): Unidentified curved bacilli on gastric epithelium in active chronic gastritis, Lancet 1, Seite 1273-1275.

[3] McNulty CAM (1999): The discovery of Campylobacter-like organisms., Westblom TU; Czinn SJ und Nedrud JG, Gastroduodenal Disease and Helicobacter pylori 241, Seite 1-9, Springer-Verlag, Berlin Heidelberg, 3-350-65084-9.

[4] Tomb, J. F.; White, O.; Kerlavage, A. R.; Clayton, R. A.; Sutton, G. G.; Fleischmann, R. D.; Ketchum, K. A.; Klenk, H. P.; Gill, S.; Dougherty, B. A.; Nelson, K.; Quackenbush, J.; Zhou, L.; Kirkness, E. F.; Peterson, S.; Loftus, B.; Richardson, D.; Dodson, R.; Khalak, H. G.; Glodek, A.; McKenney, K.; Fitzegerald, L. M.; Lee, N.; Adams, M. D.; Venter, J. C. und . (1997): The complete genome sequence of the gastric pathogen Helicobacter pylori, Nature 388 [6642], Seite 539-547.

[5] Mitchell HM (1999): The Epidemiology of Helicobacter pylori, Westblom TU; Czinn SJ und Nedrud JG, Gastroduodenal Disease and Helicobacter pylori 241, Seite 11-30, Springer-Verlag, Berlin Heidelberg, 3-350-65084-9.

[6] Zevering, Y.; Jacob, L. und Meyer, T. F. (1999): Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development, Gut 45 [3], Seite 465-474.

[7] Falush, D.; Wirth, T.; Linz, B.; Pritchard, J. K.; Stephens, M.; Kidd, M.; Blaser, M. J.; Graham, D. Y.; Vacher, S.; Perez-Perez, G. I.; Yamaoka, Y.; Megraud, F.; Otto, K.; Reichard, U.; Katzowitsch, E.; Wang, X.; Achtman, M. und Suerbaum, S. (2003): Traces of human migrations in Helicobacter pylori populations, Science 299 [5612], Seite 1582-1585.

[8] Ernst, P. B. und Gold, B. D. (2000): The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer, Annu.Rev.Microbiol. 54, Seite 615-640.

[9] El Omar, E. M. (2001): The importance of interleukin 1beta in Helicobacter pylori associated disease, Gut 48 [6], Seite 743-747.

[10] Appelmelk, B. J.; Monteiro, M. A.; Martin, S. L.; Moran, A. P. und Vandenbroucke-Grauls, C. M. (2000): Why Helicobacter pylori has Lewis antigens, Trends Microbiol. 8 [12], Seite 565-570.

[11] Rasko, D. A.; Keelan, M.; Wilson, T. J. und Taylor, D. E. (2001): Lewis antigen expression by Helicobacter pylori, J.Infect.Dis. 184 [3], Seite 315-321.

[12] Labenz J.; Meining A.; Tillenburg B. und Stolte M. (1999): Helicobacteriose: Update 1999, Leber Magen Darm 29 [2], Seite 80-92.

[13] Sutton, P. (2001): Progress in vaccination against Helicobacter pylori, Vaccine 19 [17-19], Seite 2286-2290.

[14] Loffeld, R. J. und van der Hulst, R. W. (2002): Helicobacter pylori and gastro-oesophageal reflux disease: association and clinical implications. To treat or not to treat with anti-H. pylori therapy?, Scand.J.Gastroenterol.Suppl [236], Seite 15-18.

[15] Peek, R. M., Jr. und Blaser, M. J. (2002): Helicobacter pylori and gastrointestinal tract adenocarcinomas, Nat.Rev.Cancer 2 [1], Seite 28-37.

[16] Kotloff, K. L.; Sztein, M. B.; Wasserman, S. S.; Losonsky, G. A.; DiLorenzo, S. C. und Walker, R. I. (2001): Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection, Infect.Immun. 69 [6], Seite 3581-3590.

[17] Aebischer, T.; Lucas, B.; Koesling, J.; Bumann, D. und Meyer, T. F. (2000): How CD4(+) T cells may eliminate extracellular gastric Helicobacter?, J.Biotechnol. 83 [1-2], Seite 77-84.

[18] Bumann, D.; Holland, P.; Siejak, F.; Koesling, J.; Sabarth, N.; Lamer, S.; Zimny-Arndt, U.; Jungblut, P. R. und Meyer, T. F. (2002): A Comparison of Murine and Human Immunoproteomes of Helicobacter pylori Validates the Preclinical Murine Infection Model for Antigen Screening, Infect.Immun. 70 [11], Seite 6494-6498.

[19] Jungblut, P. R. (2001): Proteome analysis of bacterial pathogens, Microbes.Infect. 3 [10], Seite 831-840.

[20] Wasinger, V. C.; Cordwell, S. J.; Cerpa-Poljak, A.; Yan, J. X.; Gooley, A. A.; Wilkins, M. R.; Duncan, M. W.; Harris, R.; Williams, K. L. und Humphery-Smith, I. (1995): Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium, Electrophoresis 16 [7], Seite 1090-1094.

[21] Rabilloud, T. (2002): Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains, Proteomics. 2 [1], Seite 3-10.

[22] Klose, J. (1975): Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals, Humangenetik. 26 [3], Seite 231-243.

[23] O'Farrell, P. H. (1975): High resolution two-dimensional electrophoresis of proteins, J.Biol.Chem. 250 [10], Seite 4007-4021.

[24] Jungblut, P.; Thiede, B.; Zimny-Arndt, U.; Muller, E. C.; Scheler, C.; Wittmann-Liebold, B. und Otto, A. (1996): Resolution power of two-dimensional electrophoresis and identification of proteins from gels, Electrophoresis 17 [5], Seite 839-847.

[25] Jungblut, P. R.; Bumann, D.; Haas, G.; Zimny-Arndt, U.; Holland, P.; Lamer, S.; Siejak, F.; Aebischer, A. und Meyer, T. F. (2000): Comparative proteome analysis of Helicobacter pylori, Mol.Microbiol. 36 [3], Seite 710-725.

[26] Pleissner, K. P.; Eifert, T.; Buettner, S.; Schmidt, F.; Boehme, M.; Meyer, T. F.; Kaufmann, S. H. und Jungblut, P. R. (2004): Web-accessible proteome databases for microbial research, Proteomics. 4 [5], Seite 1305-1313.

[27] Bumann, D.; Aksu, S.; Wendland, M.; Janek, K.; Zimny-Arndt, U.; Sabarth, N.; Meyer, T. F. und Jungblut, P. R. (2002): Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori, Infect.Immun. 70 [7], Seite 3396-3403.

[28] Sabarth, N.; Lamer, S.; Zimny-Arndt, U.; Jungblut, P. R.; Meyer, T. F. und Bumann, D. (2002): Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis, J.Biol.Chem. 277 [31], Seite 27896-27902.

[29] Bumann, D.; Metzger, W. G.; Mansouri, E.; Palme, O.; Wendland, M.; Hurwitz, R.; Haas, G.; Aebischer, T.; von Specht, B. U. und Meyer, T. F. (2001): Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers, Vaccine 20 [5-6], Seite 845-852.

[30] Koesling, J.; Lucas, B.; Develioglou, L.; Aebischer, T. und Meyer, T. F. (2001): Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy, Vaccine 20 [3-4], Seite 413-420.

[31] Rizos, K.; Lattemann, C. T.; Bumann, D.; Meyer, T. F. und Aebischer, T. (2003): Autodisplay: efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains, Infect.Immun. 71 [11], Seite 6320-6328.

[32] Metzger, W. G.; Mansouri, E.; Kronawitter, M.; Diescher, S.; Soerensen, M.; Hurwitz, R.; Bumann, D.; Aebischer, T.; von Specht, B. U. und Meyer, T. F. (2004): Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers, Vaccine 22 [17-18], Seite 2273-2277.

[33] Rollenhagen, C.; Sorensen, M.; Rizos, K.; Hurvitz, R. und Bumann, D. (2004): Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen, Proc.Natl.Acad.Sci.U.S.A 101 [23], Seite 8739-8744.

[34] Krah, A. und Jungblut, P. R. (2004): Immunoproteomics, Methods Mol.Med. 94, Seite 19-32.

[35] McAtee, C. P.; Lim, M. Y.; Fung, K.; Velligan, M.; Fry, K.; Chow, T. und Berg, D. E. (1998): Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by two-dimensional gel electrophoresis, sequence analysis, and serum profiling, Clin.Diagn.Lab Immunol., Seite 537-542.

[36] Bumann, D.; Meyer, T. F. und Jungblut, P. R. (2001): Proteome analysis of the common human pathogen Helicobacter pylori, Proteomics. 1 [4], Seite 473-479.

[37] Kimmel, B.; Bosserhoff, A.; Frank, R.; Gross, R.; Goebel, W. und Beier, D. (2000): Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies, Infect.Immun. 68 [2], Seite 915-920.

[38] Haas, G.; Karaali, G.; Ebermayer, K.; Metzger, W. G.; Lamer, S.; Zimny-Arndt, U.; Diescher, S.; Goebel, U. B.; Vogt, K.; Roznowski, A. B.; Wiedenmann, B. J.; Meyer, T. F.; Aebischer, T. und Jungblut, P. R. (2002): Immunoproteomics of Helicobacter pylori infection and relation to gastric disease, Proteomics. 2 [3], Seite 313-324.

[39] Dunn, B. E.; Perez-Perez, G. I. und Blaser, M. J. (1989): Two-dimensional gel electrophoresis and immunoblotting of Campylobacter pylori proteins, Infect.Immun. 57 [6], Seite 1825-1833.

[40] Lock, R. A.; Coombs, G. W.; McWilliams, T. M.; Pearman, J. W.; Grubb, W. B.; Melrose, G. J. und Forbes, G. M. (2002): Proteome analysis of highly immunoreactive proteins of Helicobacter pylori, Helicobacter. 7 [3], Seite 175-182.

[41] McAtee, C. P.; Fry, K. E. und Berg, D. E. (1998): Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by "proteome" technologies, Helicobacter. 3 [3], Seite 163-169.

[42] Utt, M.; Nilsson, I.; Ljungh, A. und Wadstrom, T. (2002): Identification of novel immunogenic proteins of Helicobacter pylori by proteome technology, J.Immunol.Methods 259 [1-2], Seite 1-10.

[43] Sabarth, N.; Hurwitz, R.; Meyer, T. F. und Bumann, D. (2002): Multiparameter Selection of Helicobacter pylori Antigens Identifies Two Novel Antigens with High Protective Efficacy, Infect.Immun. 70 [11], Seite 6499-6503.

[44] Nilsson, C.; Sillen, A.; Eriksson, L.; Strand, M. L.; Enroth, H.; Normark, S.; Falk, P. und Engstrand, L. (2003): Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal disease, Infect.Immun. 71 [11], Seite 6573-6581.

[45] Graham, D. Y. und Yamaoka, Y. (2000): Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise, Helicobacter. 5 Suppl 1, Seite S3-S9.

[46] Farthing, M. J.; Fitzgerald, R. und Zhang, Z. W. (2001): Acid, helicobacter and immunity: a new paradigm for oesophagogastric cancer, J.Physiol Paris 95 [1-6], Seite 423-427.

[47] McColl, K. E. und el Omar, E. (1996): Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer, Scand.J.Gastroenterol.Suppl 215, Seite 32-37.

[48] Hansson, L. E.; Nyren, O.; Hsing, A. W.; Bergstrom, R.; Josefsson, S.; Chow, W. H.; Fraumeni, J. F., Jr. und Adami, H. O. (1996): The risk of stomach cancer in patients with gastric or duodenal ulcer disease, N.Engl.J.Med. 335 [4], Seite 242-249.

[49] Graham, D. Y. (1997): Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model, Gastroenterology 113 [6], Seite 1983-1991.

[50] Parsonnet, J.; Friedman, G. D.; Vandersteen, D. P.; Chang, Y.; Vogelman, J. H.; Orentreich, N. und Sibley, R. K. (1991): Helicobacter pylori infection and the risk of gastric carcinoma, N.Engl.J.Med. 325 [16], Seite 1127-1131.

[51] Uemura, N.; Okamoto, S.; Yamamoto, S.; Matsumura, N.; Yamaguchi, S.; Yamakido, M.; Taniyama, K.; Sasaki, N. und Schlemper, R. J. (2001): Helicobacter pylori infection and the development of gastric cancer, N.Engl.J.Med. 345 [11], Seite 784-789.

[52] Calam, J. und Baron, J. H. (2001): ABC of the upper gastrointestinal tract: Pathophysiology of duodenal and gastric ulcer and gastric cancer, BMJ 323 [7319], Seite 980-982.

[53] El Omar, E. M.; Oien, K.; El Nujumi, A.; Gillen, D.; Wirz, A.; Dahill, S.; Williams, C.; Ardill, J. E. und McColl, K. E. (1997): Helicobacter pylori infection and chronic gastric acid hyposecretion, Gastroenterology 113 [1], Seite 15-24.

[54] El Omar, E. M.; Carrington, M.; Chow, W. H.; McColl, K. E.; Bream, J. H.; Young, H. A.; Herrera, J.; Lissowska, J.; Yuan, C. C.; Rothman, N.; Lanyon, G.; Martin, M.; Fraumeni, J. F., Jr. und Rabkin, C. S. (2000): Interleukin-1 polymorphisms associated with increased risk of gastric cancer, Nature 404 [6776], Seite 398-402.

[55] Furuta, T.; El Omar, E. M.; Xiao, F.; Shirai, N.; Takashima, M.; Sugimura, H. und Sugimurra, H. (2002): Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan, Gastroenterology 123 [1], Seite 92-105.

[56] Alm, R. A.; Ling, L. S.; Moir, D. T.; King, B. L.; Brown, E. D.; Doig, P. C.; Smith, D. R.; Noonan, B.; Guild, B. C.; deJonge, B. L.; Carmel, G.; Tummino, P. J.; Caruso, A.; Uria-Nickelsen, M.; Mills, D. M.; Ives, C.; Gibson, R.; Merberg, D.; Mills, S. D.; Jiang, Q.; Taylor, D. E.; Vovis, G. F. und Trust, T. J. (1999): Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori, Nature 397 [6715], Seite 176-180.

[57] Ogura, K.; Maeda, S.; Nakao, M.; Watanabe, T.; Tada, M.; Kyutoku, T.; Yoshida, H.; Shiratori, Y. und Omata, M. (2000): Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil, J.Exp.Med. 192 [11], Seite 1601-1610.

[58] Joyce, E. A.; Chan, K.; Salama, N. R. und Falkow, S. (2002): Redefining bacterial populations: a post-genomic reformation, Nat.Rev.Genet. 3 [6], Seite 462-473.

[59] Schmidt, F.; Schmid, M.; Jungblut, P. R.; Mattow, J.; Facius, A. und Pleissner, K. P. (2003): Iterative data analysis is the key for exhaustive analysis of peptide mass fingerprints from proteins separated by two-dimensional electrophoresis, J.Am.Soc.Mass Spectrom. 14 [9], Seite 943-956.

[60] Chang, J. W.; Young, D. A.; Coleman, P. D. und O'Banion, M. K. (2001): Two-dimensional gel analysis of secreted proteins induced by interleukin-1 beta in rat astrocytes, Neurochem.Int. 39 [5-6], Seite 349-359.

[61] Houry, W. A.; Frishman, D.; Eckerskorn, C.; Lottspeich, F. und Hartl, F. U. (1999): Identification of in vivo substrates of the chaperonin GroEL, Nature 402 [6758], Seite 147-154.

[62] Imam-Sghiouar, N.; Laude-Lemaire, I.; Labas, V.; Pflieger, D.; Le Caer, J. P.; Caron, M.; Nabias, D. K. und Joubert-Caron, R. (2002): Subproteomics analysis of phosphorylated proteins: application to the study of B-lymphoblasts from a patient with Scott syndrome, Proteomics. 2 [7], Seite 828-838.

[63] Stancato, L. F. und Petricoin, E. F., III (2001): Fingerprinting of signal transduction pathways using a combination of anti-phosphotyrosine immunoprecipitations and two-dimensional polyacrylamide gel electrophoresis, Electrophoresis 22 [10], Seite 2120-2124.

[64] Steinitz, M. und Tamir, S. (1995): An improved method to create nitrocellulose particles suitable for the immobilization of antigen and antibody, J.Immunol.Methods 187 [1], Seite 171-177.

[65] Fenn, J. B. et. al.:Proc 36th Annual Conference, Am. Soc. for Mass Spectrom., 05.-10.06.1988, San Francisco.

[66] Tanaka, K., Ido, Y., Akita, S., Yoshida, Y., and Yoshida, T.:Proc. Second Japan-China Joint Symposium on Mass Spectrometry 15.-18.09.1987 in Osaka, Japan.

[67] Karas, M. und Hillenkamp, F. (1988): Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons, Anal.Chem. 60 [20], Seite 2299-2301.

[68] Karas, M.; Gluckmann, M. und Schafer, J. (2000): Ionization in matrix-assisted laser desorption/ionization: singly charged molecular ions are the lucky survivors, J.Mass Spectrom. 35 [1], Seite 1-12.

[69] Zolg, J. W. und Langen, H. (2004): How industry is approaching the search for new diagnostic markers and biomarkers, Mol.Cell Proteomics. 3 [4], Seite 345-354.

[70] Mann M.:Proceedings of the 43rd ASMS Conference on Mass Spectrometry and Applied Topics, Altana, GA.

[71] Pleissner, K. P.; Regitz-Zagrosek, V.; Krudewagen, B.; Trenkner, J.; Hocher, B. und Fleck, E. (1998): Effects of renovascular hypertension on myocardial protein patterns: analysis by computer-assisted two-dimensional gel electrophoresis, Electrophoresis 19 [11], Seite 2043-2050.

[72] Pun, T.; Hochstrasser, D. F.; Appel, R. D.; Funk, M.; Villars-Augsburger, V. und Pellegrini, C. (1988): Computerized classification of two-dimensional gel electrophoretograms by correspondence analysis and ascendant hierarchical clustering, Appl.Theor.Electrophor. 1 [1], Seite 3-9.

[73] Schmid, H. R.; Schmitter, D.; Blum, P.; Miller, M. und Vonderschmitt, D. (1995): Lung tumor cells: a multivariate approach to cell classification using two-dimensional protein pattern, Electrophoresis 16 [10], Seite 1961-1968.

[74] Krah, A.; Wessel, R. und Pleissner, K. P. (2004): Assessment of Protein Spot Components Applying Correspondence Analysis for Peptide Mass Fingerprint Data, Proteomics. in press.

[75] Klade, C. S. (2002): Proteomics approaches towards antigen discovery and vaccine development, Curr.Opin.Mol.Ther. 4 [3], Seite 216-223.

[76] Klose, J. und Kobalz, U. (1995): Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome, Electrophoresis 16 [6], Seite 1034-1059.

[77] Jungblut, P.; Eckerskorn, C.; Lottspeich, F. und Klose, J. (1990): Blotting efficiency investigated by using two-dimensional electrophoresis, hydrophobic membranes and proteins from different sources, Electrophoresis 11 [7], Seite 581-588.

[78] Perkins, D. N.; Pappin, D. J.; Creasy, D. M. und Cottrell, J. S. (1999): Probability-based protein identification by searching sequence databases using mass spectrometry data, Electrophoresis 20 [18], Seite 3551-3567.

[79] Barthel, M.; Hapfelmeier, S.; Quintanilla-Martinez, L.; Kremer, M.; Rohde, M.; Hogardt, M.; Pfeffer, K.; Russmann, H. und Hardt, W. D. (2003): Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host, Infect.Immun. 71 [5], Seite 2839-2858.

[80] Jungblut, P. R. und Seifert, R. (1990): Analysis by high-resolution two-dimensional electrophoresis of differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells, J.Biochem.Biophys.Methods 21 [1], Seite 47-58.

[81] Iaquinto, G.; Todisco, A.; Giardullo, N.; D'Onofrio, V.; Pasquale, L.; De Luca, A.; Andriulli, A.; Perri, F.; Rega, C.; De Chiara, G.; Landi, M.; Taccone, W.; Leandro, G. und Figura, N. (2000): Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development, Dig.Liver Dis. 32 [5], Seite 378-383.

[82] Keller, B. O. und Li, L. (2000): Discerning matrix-cluster peaks in matrix-assisted laser desorption/ionization time-of-flight mass spectra of dilute peptide mixtures, J.Am.Soc.Mass Spectrom. 11 [1], Seite 88-93.

[83] Ding, Q.; Xiao, L.; Xiong, S.; Jia, Y.; Que, H.; Guo, Y. und Liu, S. (2003): Unmatched masses in peptide mass fingerprints caused by cross-contamination: An updated statistical result, Proteomics. 3 [7], Seite 1313-1317.

[84] Harris, W. A.; Janecki, D. J. und Reilly, J. P. (2002): Use of matrix clusters and trypsin autolysis fragments as mass calibrants in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Rapid Commun.Mass Spectrom. 16 [18], Seite 1714-1722.

[85] Krah, A.; Miehlke, S.; Pleissner, K. P.; Zimny-Arndt, U.; Kirsch, C.; Lehn, N.; Meyer, T. F.; Jungblut, P. R. und Aebischer, T. (2004): Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma, Int.J.Cancer 108 [3], Seite 456-463.

[86] Schmidt, F.; Lueking, A.; Nordhoff, E.; Gobom, J.; Klose, J.; Seitz, H.; Egelhofer, V.; Eickhoff, H.; Lehrach, H. und Cahill, D. J. (2002): Generation of minimal protein identifiers of proteins from two-dimensional gels and recombinant proteins, Electrophoresis 23 [4], Seite 621-625.

[87] Krah, A.; Schmidt, F.; Becher, D.; Schmid, M.; Albrecht, D.; Rack, A.; Buttner, K. und Jungblut, P. R. (2003): Analysis of Automatically Generated Peptide Mass Fingerprints of Cellular Proteins and Antigens from Helicobacter pylori 26695 Separated by Two-dimensional Electrophoresis, Mol.Cell Proteomics. 2 [12], Seite 1271-1283.

[88] Enroth, H.; Akerlund, T.; Sillen, A. und Engstrand, L. (2000): Clustering of clinical strains of Helicobacter pylori analyzed by two-dimensional gel electrophoresis, Clin.Diagn.Lab Immunol. 7 [2], Seite 301-306.

[89] Yamaguchi, H.; Osaki, T.; Kai, M.; Taguchi, H. und Kamiya, S. (2000): Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori, Infect.Immun. 68 [6], Seite 3448-3454.

[90] Gonzalez, C. A.; Sala, N. und Capella, G. (2002): Genetic susceptibility and gastric cancer risk, Int.J.Cancer 100 [3], Seite 249-260.

[91] Kandror, O.; Busconi, L.; Sherman, M. und Goldberg, A. L. (1994): Rapid degradation of an abnormal protein in Escherichia coli involves the chaperones GroEL and GroES, J.Biol.Chem. 269 [38], Seite 23575-23582.

[92] Wood, Z. A.; Poole, L. B.; Hantgan, R. R. und Karplus, P. A. (2002): Dimers to doughnuts: redox-sensitive oligomerization of 2-cysteine peroxiredoxins, Biochemistry 41 [17], Seite 5493-5504.

[93] Shibayama, K.; Kamachi, K.; Nagata, N.; Yagi, T.; Nada, T.; Doi, Y.; Shibata, N.; Yokoyama, K.; Yamane, K.; Kato, H.; Iinuma, Y. und Arakawa, Y. (2003): A novel apoptosis-inducing protein from Helicobacter pylori, Mol.Microbiol. 47 [2], Seite 443-451.

[94] McGovern, K. J.; Blanchard, T. G.; Gutierrez, J. A.; Czinn, S. J.; Krakowka, S. und Youngman, P. (2001): gamma-Glutamyltransferase is a Helicobacter pylori virulence factor but is not essential for colonization, Infect.Immun. 69 [6], Seite 4168-4173.

[95] Wolf, K.; Fischer, E.; Mead, D.; Zhong, G.; Peeling, R.; Whitmire, B. und Caldwell, H. D. (2001): Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation- dependent determinants, Infect.Immun. 69 [5], Seite 3082-3091.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: